Last reviewed · How we verify
NCT04816253
Controlling Post-extraction Complications of Impacted Mandibular Third Molar
NA trial testing Normal saline in Preventing Postextraction Complication in 72 participants. Completed in 20 June 2021.
20 June 2021
Quick facts
| Lead sponsor | Al-Azhar University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 10 February 2021 |
| Primary completion | 20 June 2021 |
| Estimated completion | 20 June 2021 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Normal saline
- Hyaluronic acid (HYALURONIC ACID) — full drug profile →
- Methylprednisolone (methylprednisolone) — full drug profile →
- Methylprednisolone and Hyaluronic acid — full drug profile →
Conditions studied
- Preventing Postextraction Complication — all drugs for Preventing Postextraction Complication →
Sponsor
Al-Azhar University
Who can join
Adults 20 to 35, any sex, with Preventing Postextraction Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Impacted mandibular 3rd molar will be extracted in all patients, then patients will be divided, according to material placed in extraction socket into 3 groups: control, hyaluronic acid and honey. Then post extraction complications will be evaluated
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Methylprednisolone and Hyaluronic Acid versus Each Agent Alone to Control Complication of Impacted Wisdom Removal.
Altaweel AA, Gaber AE, Alnaffar MZ, Alshomrani EA, et al · · 2022 · PMID 35368756 · DOI 10.1155/2022/1563513
Verify or expand the search:
- PubMed search for NCT04816253
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Normal saline
Trials testing the same drug.
- NCT06406829 — Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy · NA · not yet recruiting
- NCT07370181 — Ketamine Irrigation Analgesia in Laparoscopic Cholecystectomy · Phase 3 · not yet recruiting
- NCT05450328 — Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation · Phase 2 · not yet recruiting
- NCT07101367 — A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Under · Phase 1, PHASE2 · not yet recruiting
- NCT07345715 — Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy · NA · recruiting
Other Al-Azhar University trials
Trials by the same sponsor.
- NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
- NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
- NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
- NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
- NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04816253 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
- Last refreshed: 22 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04816253.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing